Back to Journals » Cancer Management and Research » Volume 3 » default

Cancer Management and Research


Archive: Volume 3, 2011

Erratum

Krikeli M, Ekonomopoulou MT, Tzitzikas I, Goutzioulis A, Mystakidou K, Pistevou-Gompaki K

Cancer Management and Research 2011, 3:319-320

Published Date: 5 December 2011

Patient–provider communication data: linking process and outcomes in oncology care

Kennedy Sheldon L, Hong F, Berry DL

Cancer Management and Research 2011, 3:311-317

Published Date: 18 November 2011

Effects of CXCR4 siRNA/dextran-spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver

Abedini F, Ismail M, Hosseinkhani H, Tengku Ibrahim TA, Omar AR, Chong PP, Hair Bejo M, Domb AJ

Cancer Management and Research 2011, 3:301-309

Published Date: 9 September 2011

Use of capecitabine in management of early colon cancer

Hameed H, Cassidy J

Cancer Management and Research 2011, 3:295-299

Published Date: 19 August 2011

Prophylactic cranial irradiation in non-small cell lung cancer patients: who might be the candidates?

Dimitropoulos C, Hillas G, Nikolakopoulou S, Kostara K, Sagris K, Vlastos F, Alchanatis M

Cancer Management and Research 2011, 3:287-294

Published Date: 17 August 2011

Use of neutral plasma coagulation in groin node dissection for vulvar malignancy: a novel technique

Madhuri TK, Tailor A, Butler-Manuel S

Cancer Management and Research 2011, 3:253-255

Published Date: 6 July 2011

Comparison of the impact of radiotherapy and radiochemotherapy on the quality of life of 1-year survivors with cervical cancer

Krikeli M, Ekonomopoulou MT, Tzitzikas I, Goutzioulis A, Mystakidou K, Pistevou-Gompaki K

Cancer Management and Research 2011, 3:247-251

Published Date: 6 July 2011

Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia

Molica S, Mirabelli R, Molica M, Levato L, Mauro F, Foà R

Cancer Management and Research 2011, 3:211-217

Published Date: 1 June 2011

Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics

Wacheck V, Lahn M, Dickinson G, Füreder W, Meyer R, Herndlhofer S, Füreder T, Dorfner G, Pillay S, André V, Burkholder TP, Akunda JK, Flye-Blakemore L, Van Bockstaele D, Schlenk RF, Sperr W, Valent P

Cancer Management and Research 2011, 3:157-175

Published Date: 10 May 2011

Interpreting clinical assays for histone deacetylase inhibitors

Martinet N, Bertrand P

Cancer Management and Research 2011, 3:117-141

Published Date: 9 May 2011

Improving evaluation of the distribution and density of immunostained cells in breast cancer using computerized video image analysis

Coventry BJ, Weightman MJ, Skinner JM, Bradley J

Cancer Management and Research 2011, 3:101-108

Published Date: 18 April 2011

Chemoprevention of prostate cancer with nutrients and supplements

Van Poppel H, Tombal B

Cancer Management and Research 2011, 3:91-100

Published Date: 6 April 2011

Capecitabine in the management of colorectal cancer

Hirsch BR, Zafar SY

Cancer Management and Research 2011, 3:79-89

Published Date: 24 March 2011

Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia

David L DeRemer, Katerina Katsanevas, Celalettin Ustun

Cancer Management and Research 2011, 3:65-78

Published Date: 10 March 2011

Critical appraisal of trastuzumab in treatment of advanced stomach cancer

Judith Meza-Junco, Heather-Jane Au, Michael B Sawyer

Cancer Management and Research 2011, 3:57-64

Published Date: 3 March 2011

Cardiovascular risk during hormonal treatment in patients with prostate cancer

Hein Van Poppel, Bertrand Tombal

Cancer Management and Research 2011, 3:49-55

Published Date: 2 March 2011

Kefir induces cell-cycle arrest and apoptosis in HTLV-1-negative malignant T-lymphocytes

Katia Maalouf, Elias Baydoun, Sandra Rizk

Cancer Management and Research 2011, 3:39-47

Published Date: 14 February 2011

Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies

Gina M Mantia-Smaldone, Robert P Edwards, Anda M Vlad

Cancer Management and Research 2011, 3:25-38

Published Date: 30 December 2010

Colonic polyps: inheritance, susceptibility, risk evaluation, and diagnostic management

Emanuele Neri, Lorenzo Faggioni, Lorenzo Cini, et al

Cancer Management and Research 2011, 3:17-24

Published Date: 30 December 2010

From antiangiogenesis to hypoxia: current research and future directions

Christopher Rice, L Eric Huang

Cancer Management and Research 2011, 3:9-16

Published Date: 20 December 2010

Reduced cancer risk in vegetarians: an analysis of recent reports

Amy Joy Lanou, Barbara Svenson

Cancer Management and Research 2011, 3:1-8

Published Date: 20 December 2010